Global Pharmaceuticals & Biotech High Insider Buying

Pfizer

Market Cap: US$125.5b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Bristol-Myers Squibb

Market Cap: US$104.5b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

CSL

Market Cap: AU$118.2b

Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

GSK

Market Cap: UK£54.6b

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Moderna

Market Cap: US$10.4b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Medpace Holdings

Market Cap: US$9.3b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

CSPC Pharmaceutical Group

Market Cap: HK$64.3b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally.

Repligen

Market Cap: US$7.1b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Bruker

Market Cap: US$6.1b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Elanco Animal Health

Market Cap: US$4.3b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Viking Therapeutics

Market Cap: US$2.6b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Grand Pharmaceutical Group

Market Cap: HK$19.6b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Alembic Pharmaceuticals

Market Cap: ₹166.4b

Develops, manufactures, and markets pharmaceutical products in India and internationally.

AddLife

Market Cap: SEK 18.8b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

Biohaven

Market Cap: US$1.9b

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.

Mesoblast

Market Cap: AU$2.2b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

SSY Group

Market Cap: HK$8.9b

An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

Indivior

Market Cap: UK£867.1m

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Ardelyx

Market Cap: US$1.1b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

10x Genomics

Market Cap: US$1.0b

A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.

89bio

Market Cap: US$864.2m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.

Geron

Market Cap: US$840.7m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

HBM Holdings

Market Cap: HK$6.5b

A clinical-stage biopharmaceutical company, engages in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas.

Arcus Biosciences

Market Cap: US$812.8m

A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.

Avadel Pharmaceuticals

Market Cap: US$746.9m

Operates as a biopharmaceutical company in the United States.

Biotage

Market Cap: SEK 7.3b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

AbCellera Biologics

Market Cap: US$727.1m

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Phibro Animal Health

Market Cap: US$725.4m

Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.

Nuvation Bio

Market Cap: US$684.1m

A clinical-stage biopharmaceutical company, focuses on unmet needs in oncology by developing differentiated and novel therapeutic candidates.

Immunome

Market Cap: US$639.1m

A clinical-stage biotechnology company, develops targeted cancer therapies.

Savara

Market Cap: US$610.4m

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

Swedencare

Market Cap: SEK 5.9b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

MedCap

Market Cap: SEK 5.8b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

Abbisko Cayman

Market Cap: HK$4.5b

Engages in the discovering and developing small molecule oncology therapies in China.

Niagen Bioscience

Market Cap: US$478.4m

Operates as a bioscience company engages in developing healthy aging products.

CStone Pharmaceuticals

Market Cap: HK$3.6b

A biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and internationally.